SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Liu Zhijing CBPO

(Last)

(First)

(Middle)

18TH FLOOR, JIALONG INTERNATIONAL BLD.

CHAOYANG PARK ROAD

(Street)

BEIJING

100125

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/07/2012

3. Issuer Name and Ticker or Trading Symbol
China Biologic Products, Inc. [ CBPO ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Vice President

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Restricted Stock⁽¹⁾	5,000	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (right to buy)⁽²⁾	⁽²⁾	07/11/2020	Common Stock	8,000⁽²⁾	$12.26	D
Stock Option (right to buy)⁽³⁾	⁽³⁾	08/31/2022	Common Stock	15,000⁽³⁾	$9.85	D

Explanation of Responses:

1. Represents restricted stock granted to the Reporting Person, under the Issuer's 2008 equity incentive plan, pursuant to a restricted stock grant agreement dated August 31, 2012. The restricted stock will vest annually over a 4-year period in four equal portions, with the initial vesting date being September 1, 2013, provided that the Reporting Person is employed by the Issuer on each vesting date.

2. Represents ten year non-qualified stock options to purchase 8,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated July 11, 2010. The options will vest in 12 equal portions on a quarterly basis over a three-year period, with the initial vesting date being October 11, 2010, provided that the Reporting Person is employed by the Issuer on each vesting date.

3. Represents ten year non-qualified stock options to purchase 15,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated August 31, 2012. The options will vest annually over a 4-year period in four equal portions, with the initial vesting date being September 1, 2013, provided that the Reporting Person is employed by the Issuer on each vesting date.

	/s/ Liu, Zhijing CBPO	04/27/2013
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.